INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Public company

Matinas BioPharma Holdings, Inc.

MTNBCIK 0001582554

EDGAR filingsOpen in network
Price$1.19
1 year+5.1%
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score9
Connections with evidence4

MTNB · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MK
Murphy KeithDirector
MTNBMatinas BioPharma Holdings, Inc.
Grant or award
A—
5,000 sh
Nov 6, 2026Nov 6, 2026

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 6, 2026
  • ← Insider ofevidence
    Murphy KeithDirector · Nov 6, 2026
  • ← Insider ofevidence
    D An EvelynDirector · Nov 6, 2026
  • ← Insider ofevidence
    Neugeboren EdwardDirector · Nov 6, 2026
traded Nov 6, 2026
+0d
SEC FORM 4

Evidence

9
DE
D An EvelynDirector
MTNBMatinas BioPharma Holdings, Inc.
Grant or award
A—
5,000 sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC FORM 4

Evidence

9
NE
Neugeboren EdwardDirector
MTNBMatinas BioPharma Holdings, Inc.
Grant or award
A—
5,000 sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC FORM 4

Evidence